Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Amortizatization of Intangibles: 2010-2021

Historic Amortizatization of Intangibles for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2021 value amounting to $4.1 million.

  • Neurocrine Biosciences' Amortizatization of Intangibles fell 14.58% to $4.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $16.2 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $26.2 million for FY2024, which is 43.17% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Amortizatization of Intangibles of $4.1 million as of Q4 2021, which was down 2.38% from $4.2 million recorded in Q3 2021.
  • Neurocrine Biosciences' Amortizatization of Intangibles' 5-year high stood at $5.2 million during Q3 2020, with a 5-year trough of -$269,000 in Q1 2017.
  • In the last 3 years, Neurocrine Biosciences' Amortizatization of Intangibles had a median value of $4.8 million in 2019 and averaged $4.6 million.
  • In the last 5 years, Neurocrine Biosciences' Amortizatization of Intangibles surged by 1,685.50% in 2018 and then decreased by 22.00% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Amortizatization of Intangibles (Quarterly) stood at $4.2 million in 2017, then climbed by 9.04% to $4.6 million in 2018, then rose by 5.26% to $4.8 million in 2019, then remained steady at $4.8 million in 2020, then declined by 14.58% to $4.1 million in 2021.
  • Its Amortizatization of Intangibles was $4.1 million in Q4 2021, compared to $4.2 million in Q3 2021 and $4.0 million in Q2 2021.